ELISA
High-Throughput ELISA Assays with Unmatched Speed and Quality
Dash’s ELISA platform delivers highly consistent, flexible, and scalable assay execution with unmatched speed and quality. With integrated plate washing, reading, incubating, and shaking, we efficiently execute ELISA assays to support critical applications such as PK, PD, ADA, biomarker analysis, and cytokine panels.
Our platform is optimized for ELISA readouts in both 96- and 384-well plate formats. We offer development of fully custom ELISA assays, rapid implementation of existing vendor kits, and pre-developed ELISA kits for common analytes, including multiplex cytokine panels.
Dash is deeply experienced in end-to-end ELISA assay development, optimization, and high-throughput execution. Our scientists bring extensive expertise across therapeutic areas and sample types, enabling us to tailor workflows for even the most complex study designs. From exploratory biomarker discovery through late-stage clinical support, we deliver actionable, reproducible ELISA data that accelerate decision-making and de-risk development programs.
Accelerated ELISA Assay Execution with a Highly Automated Bioanalysis CRO
At Dash Bio, we specialize in delivering ELISA assay services with unmatched speed, sensitivity, and precision. As a highly automated bioanalysis CRO, we streamline every stage of ELISA assay development and execution—from sample intake to data delivery—so you can accelerate decision-making and keep your development programs on track.
Our automation-first approach to ELISA assays ensures consistency, reproducibility, and dramatically shortened timelines for the studies that matter most. Whether you are measuring biomarkers, evaluating large molecule pharmacokinetics (PK), conducting ADA testing, or analyzing small molecule drug candidates, our ELISA platforms are optimized to deliver high-quality, reliable results with industry-leading turnaround times. By integrating robotics, advanced liquid handling, and intelligent workflows, we remove bottlenecks that slow traditional CROs, enabling your team to access critical data faster.
With deep expertise in ELISA assay development and bioanalysis CRO services spanning early discovery through clinical development, Dash Bio understands the unique requirements of ELISA-based biomarker assays across therapeutic areas. Our scientists bring rigor and scalability to every project, leveraging multiplexing capability, sensitive detection, and automated precision to deliver results that are not only faster, but also more reproducible and trustworthy.
When timelines are critical, you need a partner who can combine scale with quality. Dash Bio is redefining the standard for ELISA assay execution by pairing assay development expertise with next-generation automation. The result: a proven solution to accelerate studies, de-risk development pipelines, and keep your programs advancing at the pace of innovation.